Kalaris Therapeutics, Inc. (KLRS) Earnings
|
Expand Research on KLRS
| Next EPS Date | 11/18/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +1.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +11.4% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/26  |
Q326 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/26 |
Q226 | -$0.48 | -$0.50 | +$0.02 | N/A | N/A | N/A |  | | Details | |
| 5/12/26 | Q126 | -$0.46 | $0.00 | -$0.46 | N/A | N/A | N/A | | | Details | |
| 11/12/25 | Q325 | -$0.64 | $0.00 | -$0.64 | N/A | N/A | N/A | | | Details | |
| 8/13/25 |
Q325 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/13/25 | Q225 | -$0.61 | $0.00 | -$0.61 | N/A | N/A | N/A | | | Details | |
| 5/1/25 |
Q125 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
